Author:
Torino Francesco,Sarmiento Roberta,Longo Raffaelle,Gasparini Giampietro
Reference136 articles.
1. Gasparini G, Longo R, Fanelli M, Teicher BA. Combination of antiangiogenic therapy with other anticancer therapies: results, challenges, and open questions. J Clin Oncol. 2005;23:1295–311.
2. Sarmiento R, Longo R, Gasparini G. Challenges of antiangiogenic therapy of tumors. In: Figgs W, Folkman J, editors. Angiogenesis: an integrative approach from science to medicine. New York: Springer; 2008. p. 461–75.
3. Wang J, Sun Y, Liu Y, et al. Results of randomized, multicenter, double-blind phase III trial of rh-endostatin (YH-16) in treatment of advancednon-small cell lung cancer patients. Zhonqquo Fei Ai Za Zhi. 2005;8:283–90.
4. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997;275:964–7.
5. Bagley RG, Weber W, Rouleau C, et al. Pericytes and endothelial precursor cells: cellular interactions and contributions to malignancy. Cancer Res. 2005;65(21):9741–50.